ProfileGDS4718 / 241104_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 35% 33% 39% 33% 25% 30% 43% 36% 33% 35% 32% 32% 32% 22% 35% 32% 29% 29% 30% 42% 32% 34% 35% 35% 28% 34% 25% 42% 28% 28% 19% 41% 40% 23% 31% 31% 38% 44% 30% 37% 26% 24% 29% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8522237
GSM549102patient 115, normal, homogenized [OPG study]4.7609735
GSM549104patient 119, normal, homogenized [OPG study]4.6391933
GSM549108patient 138, normal, homogenized [OPG study]4.9802739
GSM549119patient 077, normal, homogenized [OPG study]4.6875333
GSM549133patient 032, cancer, homogenized [OPG study]4.2880525
GSM549139patient 042, cancer, homogenized [OPG study]4.5058430
GSM549099patient 107, normal, homogenized [OPG study]5.1436743
GSM549109patient 139, normal, homogenized [OPG study]4.84436
GSM549110patient 046, normal, homogenized [OPG study]4.6828833
GSM549114patient 063, normal, homogenized [OPG study]4.6934935
GSM549122patient 082, normal, homogenized [OPG study]4.653932
GSM549134patient 033, cancer, homogenized [OPG study]4.6107432
GSM549136patient 036, cancer, homogenized [OPG study]4.5577932
GSM549140patient 044, cancer, homogenized [OPG study]4.1935522
GSM549111patient 047, normal, homogenized [OPG study]4.7521635
GSM549113patient 057, normal, homogenized [OPG study]4.5694632
GSM549132patient 031, cancer, homogenized [OPG study]4.4827829
GSM549137patient 038, cancer, homogenized [OPG study]4.4727729
GSM549142patient 047, cancer, homogenized [OPG study]4.6510830
GSM549100patient 110, normal, homogenized [OPG study]5.0974242
GSM549107patient 135, normal, homogenized [OPG study]4.5827432
GSM549115patient 068, normal, homogenized [OPG study]4.6641334
GSM549116patient 072, normal, homogenized [OPG study]4.7213235
GSM549120patient 078, normal, homogenized [OPG study]4.7493335
GSM549131patient 030, cancer, homogenized [OPG study]4.3902928
GSM549118patient 074, normal, homogenized [OPG study]4.7103634
GSM549129patient 027, cancer, homogenized [OPG study]4.3357425
GSM549123patient 088, normal, homogenized [OPG study]5.0794442
GSM549124patient 006, cancer, homogenized [OPG study]4.5064628
GSM549126patient 015, cancer, homogenized [OPG study]4.4365228
GSM549128patient 025, cancer, homogenized [OPG study]4.1008819
GSM549103patient 117, normal, homogenized [OPG study]5.1231641
GSM549117patient 073, normal, homogenized [OPG study]4.9463140
GSM549138patient 041, cancer, homogenized [OPG study]4.2448923
GSM549141patient 045, cancer, homogenized [OPG study]4.5248631
GSM549130patient 028, cancer, homogenized [OPG study]4.6024531
GSM549101patient 111, normal, homogenized [OPG study]4.9263238
GSM549105patient 128, normal, homogenized [OPG study]5.2231244
GSM549106patient 134, normal, homogenized [OPG study]4.4817230
GSM549112patient 048, normal, homogenized [OPG study]4.8590237
GSM549125patient 011, cancer, homogenized [OPG study]4.401526
GSM549127patient 024, cancer, homogenized [OPG study]4.2603824
GSM549135patient 035, cancer, homogenized [OPG study]4.4598729